Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer
- 1 August 1991
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 338 (8762) , 274-277
- https://doi.org/10.1016/0140-6736(91)90417-n
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort studyBritish Journal of Cancer, 1989
- Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.BMJ, 1989
- Sequential use of conjugated estrogens and medroxiprogesterone in the climacteric syndrome: clinical and histological findingsMaturitas, 1988
- Long‐term surveillance of mortality and cancer incidence in women receiving hormone replacemen therapyBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- Prevention of endometrial cancer with progestogensMaturitas, 1986
- RELIABILITY OF RECALL OF DRUG USAGE AND OTHER HEALTH-RELATED INFORMATION1American Journal of Epidemiology, 1982
- Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal EndometriumNew England Journal of Medicine, 1981
- Endometrial disease after treatment with oestrogens and progestogens in the climacteric.BMJ, 1980
- PREVENTION AND TREATMENT OF ENDOMETRIAL DISEASE IN CLIMACTERIC WOMEN RECEIVING ŒSTROGEN THERAPYThe Lancet, 1979
- Sampling Methods for Random Digit DialingJournal of the American Statistical Association, 1978